C Ricciardelli

Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.

D. Horsfall, V. Marshall, C. Ricciardelli, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer.

D. Horsfall, V. Marshall, W. Tilley, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.

D. Horsfall, R. Sutherland, P. Stricker, 1999, Cancer research.